SecBot SecBot
SECBOTREPLAY Home › Report › PEN

PEN · Penumbra shareholders voted overwhelmingly to approve the merger with…

Penumbra Inc · 425 filed May 7, 2026 at 09:01 ET

At the news

BULLISHIMPACT 7/10

425 filed May 7, 2026 at 09:01 ET

Penumbra shareholders voted overwhelmingly to approve the merger with Boston Scientific, with 99.7% of votes cast in favor. The deal now awaits remaining regulatory clearances (HSR and foreign antitrust) and is expected to close in the second half of 2026.

  • 28,564,786 votes FOR the merger (99.7% of cast votes), 85,334 AGAINST, 15,813 abstentions
  • 28,665,933 shares present or proxy out of 39,324,084 outstanding (72.9% quorum)
  • Advisory compensation proposal also approved (27,811,605 FOR)
  • Merger agreement dated January 14, 2026; Penumbra to survive as wholly owned subsidiary of Boston Scientific

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access